Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association

February 16, 2020 updated by: Emmanuel Charbonney, Hopital du Sacre-Coeur de Montreal
The goal of this project, is to better understand the fluctuation of the level of uric acid in traumatized patients by making serial measurements during their hospitalization in the intensive care unit. In addition, the determinants (e.g. type of trauma, diseases, interventions) of the blood level of uric acid and its association with the development of organ failure will be sought.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

25

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montreal, Quebec, Canada, H4J1C5
        • Hôpital du Sacré-Coeur de Montreal

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Multiple trauma patients admitted in the trauma center and requiring ICU admission.

Description

Inclusion Criteria:

  • Direct admission to trauma center
  • ≤ 3h after trauma
  • ISS ≥ 16
  • Received at least 1L of fluid at ER entrance

Exclusion Criteria:

  • Isolated head injury
  • Isolated spine injury
  • Chemotherapy within the last month
  • Hematologic disease
  • Chronic hemodialysis
  • Uricase treatment within the last week
  • Expected death within 48h

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of serial plasmatic uric acid sampling after trauma
Time Frame: 7 days
Number of measures collected/number of measures planned
7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Impact of resuscitation on uric acid measures
Time Frame: 24 to 48 hours
Impact of fluid administration (amount in mL) on the changes of subsequent uric acid blood level
24 to 48 hours
Clinical predictors of the first blood uric acid (μmol/L) level measured
Time Frame: 12 hours

Impact of patient's characteristics and physiological variables on the first measured blood uric acid.

Characteristics will include: age (years), gender, Injury severity score, presence of acute renal impairment.

Physiological variables will include: lower systolic blood pressure, base deficit, lactate level

12 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 30, 2018

Primary Completion (Anticipated)

August 1, 2020

Study Completion (Anticipated)

September 1, 2020

Study Registration Dates

First Submitted

July 24, 2018

First Submitted That Met QC Criteria

August 7, 2018

First Posted (Actual)

August 9, 2018

Study Record Updates

Last Update Posted (Actual)

February 18, 2020

Last Update Submitted That Met QC Criteria

February 16, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 263425

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammation

3
Subscribe